Trials / Completed
CompletedNCT02755519
Optimizing Diagnosis Of Primary Aldosteronism
Case Detection and Confirmation, Subtype Classification of Patients With Primary Aldosteronism
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Chongqing Medical University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To optimize the confirmatory tests for primary aldosteronism.
Detailed description
In this study, the investigators aim to optimize the three confirmatory tests: salt loading, captopril challenge and fludrocortisone suppression, and to confirm a better choice of confirming testing for single or combined diagnosis of primary aldosteronism. Additionally, the investigators plan to collect blood and tissue samples of PA patients for genetic testing, and to proceed a long-term follow-up for further investigating the mechanism underlying PA and evaluating the cardio-cerebrovascular complications risk.
Conditions
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2016-04-29
- Last updated
- 2016-11-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02755519. Inclusion in this directory is not an endorsement.